HemoDynamx

Treatment for Aortic Stenosis

Health Tech & Life Sciences
Stealth Mode
Follow

Company Overview

Snapshot

Founded in March 2014 by Jarret Fass and Sagy Karavany, HemoDynamx operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of medical devices.

Business overview

HemoDynamx is a cardiovascular medical device company specializing in developing treatments for aortic stenosis. The company's core technology is focused on creating a profoundly simple treatment for this condition, serving the healthcare industry, particularly healthcare providers. It operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics.

Log in to access full profile

Company Intelligence Q&A

When was HemoDynamx founded?
HemoDynamx was founded in March 2014.
Who are the founders of HemoDynamx?
The co-founders of HemoDynamx are Jarret Fass and Sagy Karavany.
What is HemoDynamx's primary focus?
HemoDynamx is focused on developing a medical device for the treatment of aortic stenosis.
What sector does HemoDynamx operate in?
HemoDynamx operates in the Health Tech & Life Sciences sector, specifically within Medical Devices and Medical Treatment & Therapeutics.
What is the current product stage of HemoDynamx?
HemoDynamx's product is currently in the Research & Development (R&D) stage, focusing on developing a medical device solution for aortic stenosis.
Log in to access full profile